Haswanth Rao Guttikonda

Haswanth Rao Guttikonda

Active Director Director DIN 06368794
DIN 06368794 First appointment Apr 2015 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies –
Total affiliations 6 Since Apr 2015
Shareholding value •••• Premium profile

About Haswanth Rao Guttikonda

Data last updated:

Haswanth Rao Guttikonda has 11 years in corporate governance. Holds Director and Designated Partner roles. Currently with 6 companies, including Vyaghra Health Foods Private Limited and Spansules Pharmatech Private Limited. Engaged in Healthcare, Technology and more. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹241 Cr; the largest is Spansules Formulations India Private Limited at ₹166 Cr (FY 2023).

DIN 06368794
Primary Designation Director
First Appointment 24 Apr 2015
Oldest Company Age 26 yrs
Largest company Spansules Formulations India Private Limited · ₹166 Cr (FY 2023)
Combined revenue ₹241 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Mar 20222022₹166 Cr (FY 2023)Active
Spansules Pharmatech Private Limited U24230TG2000PTC035421
Director07 Feb 20202000₹73.76 Cr (FY 2025)Active
Vyaghra Health Foods Private Limited U15209TG2016PTC113315
Director24 Jan 20192016₹1.07 Cr (FY 2024)Active
Director25 Aug 20212021₹31,590 (FY 2025)Active
Director24 Apr 20152015–Active
Designated Partner08 Jan 20192019–Under Process Of Striking Off

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vyaghra Health Foods Private Limited
Spansules Pharmatech Private Limited
Spansules Formulations India Private Limited
Spansules Life Sciences Private Limited
Premium access

Shareholding and investment profile for Haswanth Rao Guttikonda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Haswanth Rao Guttikonda

Haswanth Rao Guttikonda has 11 years in corporate governance. Holds Director and Designated Partner roles. Currently with 6 companies, including Vyaghra Health Foods Private Limited and Spansules Pharmatech Private Limited. Engaged in Healthcare, Technology and more. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹241 Cr; the largest is Spansules Formulations India Private Limited at ₹166 Cr (FY 2023).

Haswanth Rao Guttikonda is associated with 6 companies as Director and Designated Partner, including Spansules Formulations India Private Limited (₹166 Cr), Spansules Pharmatech Private Limited (₹73.76 Cr), Vyaghra Health Foods Private Limited (₹1.07 Cr).

Haswanth Rao Guttikonda has expertise in Healthcare, Technology and other sectors.

Haswanth Rao Guttikonda has 11 years in corporate governance.

By reported revenue, the largest current company of Haswanth Rao Guttikonda is Spansules Formulations India Private Limited, with revenue of ₹166 Cr (FY 2023).

The 4 current companies of Haswanth Rao Guttikonda that report revenue have a combined latest revenue of ₹241 Cr.

Haswanth Rao Guttikonda currently holds positions at 6 companies; the 5 largest by reported revenue are Spansules Formulations India Private Limited (₹166 Cr), Spansules Pharmatech Private Limited (₹73.76 Cr), Vyaghra Health Foods Private Limited (₹1.07 Cr), Spansules Life Sciences Private Limited (₹31,590), Spansules Formulations Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available